会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明申请
    • CYTOKINE RECEPTOR COMMON GAMMA CHAIN LIKE
    • 细胞因子受体常见的GAMMA链样
    • WO2002068588A2
    • 2002-09-06
    • PCT/US2002/004878
    • 2002-02-20
    • HUMAN GENOME SCIENCES, INC.RUBEN, Steven, M.ROSEN, Craig, A.MOORE, Paul, A.
    • RUBEN, Steven, M.ROSEN, Craig, A.MOORE, Paul, A.
    • C12N
    • C07K14/715
    • The present invention relates to a novel human gene encoding a polypeptide which is a member of the Cytokine Receptor family. More specifically, the present invention relates to a polynucleotide encoding a novel human polypeptide named Cytokine Receptor Common Gamma Chain Like, or "CRCGCL." This invention also relates to CRCGCL polypeptides, as well as vectors, host cells, antibodies directed to CRCGCL polypeptides, and the recombinant methods for producing the same. Also provided are diagnostic methods for detecting disorders related to the immune system, and therapeutic methods for treating, diagnosing, detecting, and/or preventing such disorders. The invention further relates to screening methods for identifying agonists and antagonists of CRCGCL activity.
    • 本发明涉及编码细胞因子受体家族成员的多肽的新型人类基因。 更具体地说,本发明涉及编码命名为细胞因子受体共同γ链样的新型人类多肽或“CRCGCL”的多核苷酸。 本发明还涉及CRCGCL多肽,以及载体,宿主细胞,针对CRCGCL多肽的抗体,以及用于生产它们的重组方法。 还提供了用于检测与免疫系统相关的病症的诊断方法,以及用于治疗,诊断,检测和/或预防这些病症的治疗方法。 本发明还涉及鉴定CRCGCL活性的激动剂和拮抗剂的筛选方法。
    • 10. 发明申请
    • ANTIBODIES THAT SPECIFICALLY BIND TO REG IV
    • 特定于REG IV的抗体
    • WO2004003144A2
    • 2004-01-08
    • PCT/US2003/019908
    • 2003-06-26
    • HUMAN GENOME SCIENCES, INC.ROSEN, Craig, A.
    • ROSEN, Craig, A.
    • C12N
    • C07K16/18A61K2039/505C07K2317/21C07K2317/622
    • The present invention relates to antibodies and related molecules that specifically bind to Reg IV. Such antibodies have uses, for example, in the prevention and treatment of gastrointestinal tract cancers, inflammatory bowel disorders, and diabetes. The invention also relates to nucleic acid molecules encoding anti-Reg IV antibodies, vectors and host cells containing these nucleic acids, and methods for producing the same. The present invention relates to methods and compositions for preventing, detecting, diagnosing, treating or ameliorating a disease or disorder, especially gastrointestinal tract cancers, inflammatory bowel disorders, and diabetes, comprising administering to an animal, preferably a human, an effective amount of one or more antibodies or fragments or variants thereof, or related molecules, that specifically bind to Reg IV.
    • 本发明涉及特异性结合Reg IV的抗体和相关分子。 这样的抗体具有例如用于预防和治疗胃肠道癌症,炎症性肠病和糖尿病的用途。 本发明还涉及编码抗Reg IV抗体的核酸分子,含有这些核酸的载体和宿主细胞及其制备方法。 本发明涉及用于预防,检测,诊断,治疗或改善疾病或病症,特别是胃肠道癌症,炎症性肠病和糖尿病的方法和组合物,包括向动物,优选人类施用有效量的一种 或更多的与Reg IV特异性结合的抗体或其片段或变体,或相关分子。